Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations

Clinical trial NCT04550494 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04550494
Sponsor: National Cancer Institute (NCI)
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Anatomic Stage III Breast Cancer AJCC v8 Anatomic Stage IV Breast Cancer AJCC v8 Castration-Resistant Prostate Carcinoma Clinical Stage III Gastric Cancer AJCC v8 Clinical Stage IV Gastric Cancer AJCC v8 HER2-Positive Breast Carcinoma Locally Advanced Breast Carcinoma Locally Advanced Gastric Carcinoma Locally Advanced Malignant Solid Neoplasm Locally Advanced Ovarian Carcinoma Locally Advanced Pancreatic Carcinoma Locally Advanced Prostate Carcinoma

Start date: 2021-04-26
Primary completion: 2026-07-10
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.